The Chinese University of Hong Kong

🇨🇳China

Country: 🇨🇳China

Ownership: Private

Established: 1963-01-01

Employees: -

Market Cap: -

Website: http://www.cuhk.edu.hk

Clinical Trials

The Effects of Soy Protein and Isoflavones on Glycemic Control, Insulin Sensitivity and Cardiovascular Risk Factors

Not Applicable

Completed

Conditions: Diabetes
Cardiovascular Risk

Interventions: Dietary Supplement: soy protein
Dietary Supplement: isoflavones
Dietary Supplement: milk protein

First Posted Date: 2009-03-06

Last Posted Date: 2009-03-06

Lead Sponsor: Chinese University of Hong Kong

Registration Number: NCT00856882

Telephone Intervention in Patients With Acute Coronary Syndrome (ACS) and Diabetes

Not Applicable

Terminated

Conditions: Type 2 Diabetes Mellitus
Acute Coronary Syndrome

Interventions: Behavioral: telephone contact

First Posted Date: 2008-12-31

Last Posted Date: 2012-02-22

Lead Sponsor: Chinese University of Hong Kong

Target Recruit Count: 137

Registration Number: NCT00816010

Locations: 🇭🇰
5 public hospitals in Hong Kong, Hong Kong, Hong Kong

A Survey on the Rate of Glucose Intolerance in Hong Kong Chinese

Conditions: Impaired Glucose Tolerance (IGT)
Diabetes
Impaired Fasting Glucose (IFG)
Glucose Intolerance

First Posted Date: 2008-11-07

Last Posted Date: 2015-08-24

Lead Sponsor: Chinese University of Hong Kong

Target Recruit Count: 3000

Registration Number: NCT00787215

Locations: 🇨🇳
Gary Ko, Hong Kong, China

A Survey to Evaluate the Cardiovascular Risk Status of Subjects With Pre-Diabetes in Hong Kong

Conditions: Prediabetes
Cardiovascular Risk Factors

Interventions: Other: observational, no intervention needed

First Posted Date: 2008-11-06

Last Posted Date: 2015-08-24

Lead Sponsor: Chinese University of Hong Kong

Target Recruit Count: 3000

Registration Number: NCT00786890

Locations: 🇨🇳
Hong Kong Institute of Diabetes and Obesity, Hong Kong, China

A Survey to Evaluate the Rate of Abnormal Glucose Tolerance Among Hong Kong Chinese Subjects With Coronary Heart Disease

Withdrawn

Conditions: Diabetes Mellitus
Coronary Heart Disease

First Posted Date: 2008-11-06

Last Posted Date: 2015-08-24

Lead Sponsor: Chinese University of Hong Kong

Registration Number: NCT00786175

Locations: 🇨🇳
Hong Kong Institute of Diabetes and Obesity, Hong Kong, China

TAE and Surgery in Patients With Peptic Ulcer Bleeding Uncontrolled by Endoscopic Therapy

Not Applicable

Terminated

Conditions: Peptic Ulcer
Bleeding

Interventions: Procedure: Trans-catheter arterial embolization
Procedure: Surgery

First Posted Date: 2008-10-06

Last Posted Date: 2020-06-23

Lead Sponsor: Chinese University of Hong Kong

Target Recruit Count: 34

Registration Number: NCT00766961

Locations: 🇨🇳
Endoscopy Center, Prince of Wales Hospital, Hong Kong, China

Study on Clinical Outcome of Vascular Inflow Occlusion in Open Liver Resection

Not Applicable

Completed

Conditions: Hepatectomy

Interventions: Procedure: Intermittent Pringle maneuver

First Posted Date: 2008-08-08

Last Posted Date: 2015-02-04

Lead Sponsor: Chinese University of Hong Kong

Target Recruit Count: 126

Registration Number: NCT00730743

Locations: 🇨🇳
Prince of Wales Hospital, Hong Kong, China

Community Health Worker Reduces Care Utilization

Phase 4

Completed

Conditions: Type 2 Diabetes Mellitus

Interventions: Other: Protocol-driven care under JADE Program
Other: Additional support by CHW

First Posted Date: 2008-07-08

Last Posted Date: 2015-09-09

Lead Sponsor: Chinese University of Hong Kong

Target Recruit Count: 661

Registration Number: NCT00711152

Locations: 🇭🇰
Asia Diabetes Foundation, Hong Kong, Hong Kong

The Efficacy of Tradition Chinese Medicine in Patients With Irritable Bowel Syndrome

Phase 2

Completed

Conditions: Irritable Bowel Syndrome

Interventions: Drug: Traditional Chinese Medicine Placebo
Drug: Traditional Chinese Medicine

First Posted Date: 2008-05-13

Last Posted Date: 2017-04-25

Lead Sponsor: Chinese University of Hong Kong

Target Recruit Count: 104

Registration Number: NCT00676975

Locations: 🇨🇳
Li Ka Shing Specialist Clinic, Prince of Wales Hospital, Hong Kong (SAR), China

Steroid Induced Osteoporosis in Patients With Systemic Lupus Erythematosus

Phase 4

Completed

Conditions: Systemic Lupus Erythematosus

Interventions: Drug: Ibandronate+alfacalcidol+calcium
Drug: placebo ibandronate+alfacalcidol+calcium

First Posted Date: 2008-04-29

Last Posted Date: 2012-02-13

Lead Sponsor: Chinese University of Hong Kong

Target Recruit Count: 40

Registration Number: NCT00668330

Locations: 🇨🇳
School of Pharmacy CUHK, Hong Kong, China

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy